Jazz Pharma's decision to revoke U.S. patent for rival narcolepsy drug

Published Date: 02 Mar 2023

A U.S. court on Friday ordered Jazz Pharmaceuticals to revoke its patents related to its flagship narcolepsy drug Xyrem from the FDA-approved brand name drug after winning a case against Avadel foe CNS Pharmaceuticals.

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Weight loss and cancer; no brain tumor blood test; no cervical cancer after HPV vaccination.

2.

Modified personalized cancer vaccine generates powerful immune response

3.

AMA President-Elect Confronts a New Challenge: A Brain Tumor

4.

I Understand Why Defense Secretary Austin Kept His Prostate Cancer Quiet.

5.

findings from the measurement of disability weights in China with an emphasis on the impact of disease burden.


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot